Rosen M, Cucco R, Teirstein A.Outcome of intensive care in patients with the acquired immunodeficiency syndrome. J Intensive Care Med. 1986;1:55-60.
3.
Rosen M, Palo VD. Outcome of intensive care for patients with AIDS. Crit Care Clin N Amer. 1993;9:107-114.
4.
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2003. Vol. 15. Atlanta, Ga: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2004:1-46. Also available at: http://www.cdc.gov/hiv/stats/hasrlink.htm 2004; 2005.
5.
UN AIDS. 2004Report on the global AIDS epidemic: executive summary. Available at: http://www.unaids.org/bangkok2004/GAR2004_html/ExecSummary_en/ExecSumm_00_en.htm.
6.
Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. April 7, 2005. Available at: http://aidsinfo.nih.gov/guidelines/adult/AA_040705.pdf.
7.
Selwyn P, Forstein M.Overcoming the false dichotomy of curative vs palliative care for late-stage AIDS: “let me live the way I want to live, until I can’t”. JAMA. 2003;290:806-814.
8.
Montaner J, Russell J, Lawson L, et al.Acute respiratory failure secondary to Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a potential role for systemic corticosteroids. Chest. 1989;95:881-884.
9.
Wachter R, Russi M, Hopewell P, et al.Pneumocystis carinii pneumonia and respiratory failure in AIDS: improved outcomes and increased use of intensive care units. Am Rev Respir Dis. 1991;143:251-256.
10.
Wachter R, Luce J.Respiratory failure from severe pneumocystis carinii pneumonia: entering the third era. Chest. 1994;206:1313-1315.
11.
Stringer J, Beard C, Miller R, et al.A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis. 2002;8:891-896.
12.
Rosen M, Clayton K, Schneider R, et al.Intensive care of patients with HIV infection: utilization, critical illnesses and outcomes. Am J Respir Crit Care Med. 1997;155:67-71.
13.
Nickas G, Wachter R.Outcomes of intensive care for patients with human immunodeficiency virus infection. Arch Intern Med. 2000;160:541-547.
14.
Lazard T, Retel O, Guidet B, et al.AIDS in a medical intensive care unit: immediate prognosis and long-term survival. JAMA. 1996;276:1240-1245.
15.
Casalino E, Mendoza-Sassi G, Wolff M, et al.Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU. Chest. 1998;1998:421-429.
16.
Morris A, Creasman J, Turner J, et al.Intensive care of human immunodeficiency-virus infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med. 2002;166:262-267.
17.
Morris A, Wachter R, Luce J, et al.Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS. 2003;17:73-80.
18.
Narasimhan M, Posner A, DePalo V, et al.Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest. 2004;125:1800-1804.
19.
Jain M, Skiest D, Cloud J, et al.Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and 1999-2000. Clin Infect Dis. 2003;36:1030-1038.
20.
Khouli H, Afrasiabi A, Shibli M, et al.Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. J Intensive Care Med. 2005;20:279-285.
21.
Uphold C, Deloria-Knoll M, Palella F, et al.US hospital care for patients with HIV infection and pneumonia: the role of public, private, and Veterans Affairs hospitals in the early highly active antiretroviral therapy era. Chest. 2004;125:548-556.
22.
Parada JP, Deloria-Knoll M, Chmiel JS, et al.Relationship between health insurance and medical care for patients hospitalized with human immunodeficiency virus-related Pneumocystis carinii pneumonia, 1995-1997: Medicaid, bronchoscopy, and survival. Clin Infect Dis. 2003;37:1549-1555.
23.
Curtis JR, Yarnold PR, Schwartz DN, et al.Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 2000;162:393-398.
24.
Sansone G, Ferndale J.Impact of combination ART on causes of death in persons with late-stage AIDS. J Urban Health. 2000;77:166-175.
25.
Greub G, Ledergerner B, Battegay M, et al.Clinical progression, survival and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus. Lancet. 2000;356:1800-1805.
26.
Monga H, Rodriguez-Barrada M, Breaux K, et al.Hepatitis C infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;33:240-247.
27.
Centers for Disease Control and Prevention. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep. 2004;53(No. RR-15):1-120.
28.
Wislez M, Bergot E, Antoine M, et al.Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 2001;164:847-851.
29.
Pulmonary Complications of HIV Study Group. Design of a prospective study of the pulmonary complications of human immunodeficiency virus infection. J Clin Epidemiol. 1993;46:497-507.
30.
Beck J, Rosen M, Peavy H.Pulmonary complications of HIV infection: report of the fourth NHLBI workshop. Amer J Respir Crit Care Med. 2001;164:2120-2126.